Home-based intravenous treatment with reslizumab for severe asthma in the Netherlands – An evaluation von Bendien, S.A., van Leeuwen, M.M., Lau, H.S., Ten Brinke, A., Visser, L.E., de Koning, E.M., Braunstahl, G.J.

Volltext

Long-term weight changes after starting anti-IL-5/5Ra biologics in severe asthma: the role of oral corticosteroids von Have, L. ten, Visser, E., Meulmeester, F.L., Bendien, S.A., Braunstahl, G.J., Broeders, M.E.A.C., Fieten, K.B., Hashimoto, S., Huisstede, A. van, Langeveld, B., Oud, K.T.M., Patberg, K.W., Smeenk, F.W.J.M., Veen, A. van, Veen, I.H. van, Ven, M.J.T. van de, Weersink, E.J.M., Jong, K. de, Sont, J.K., Kroes, J.A., Brinke, A. ten

Volltext bestellen

Real-world effectiveness of IL-5/5Ra targeted biologics in severe eosinophilic asthma with comorbid bronchiectasis von Bendien, S.A., Kroes, J.A., Hal, L.H.G. van, Braunstahl, G.J., Broeders, M.E.A.C., Oud, K.T.M., Patberg, K.W., Smeenk, F.W.J.M., Veen, I.H.P.A.A. van, Weersink, E.J.M., Fieten, K.B., Hashimoto, S., Veen, A. van, Sont, J.K., Huisstede, A. van, Ven, M.J.T. van de, Langeveld, B., Zee, A.H.M.V., Brinke, A. ten

Volltext bestellen

Real-world effectiveness of reslizumab in patients with severe eosinophilic asthma: first Iinitiators and switchers von Hashimoto, S., Kroes, J.A., Eger, K.A., Asam, P.F.M., Hofstee, H.B., Bendien, S.A., Braunstahl, G.J., Broeders, M.E.A.C., Imming, L.M., Langeveld, B., Maitland-Van der Zee, A.H., Oud, K.T.M., Patberg, K.W., Smeenk, F.W.J.M., Romme, E.A.P.M., Bezouw, M.J. van, Ven, M.J. van de, Veen, A. van, Velzen, E. van, Veen, I.H.P.A.A. van, Weersink, E.J.M., Brinke, A. ten, Sont, J.K., Bel, E.H.

Volltext bestellen

Supplementary Material for: Bronchiectasis in Severe Asthma: Does It Make a Difference? von Bendien, S.A., VanLoon-Kooij, S., Kramer, G., Huijgen, W., Altenburg, J., TenBrinke, A., Maitland-VanderZee, A.-H.

Volltext bestellen